HIMS+HERS HERS A DL-0001
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides pres… Read more
Market Cap & Net Worth: HIMS+HERS HERS A DL-0001 (82W)
HIMS+HERS HERS A DL-0001 (F:82W) has a market capitalization of $4.88 Billion (€4.76 Billion) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #2947 globally and #259 in its home market, demonstrating a 8.85% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying HIMS+HERS HERS A DL-0001's stock price €21.70 by its total outstanding shares 219270891 (219.27 Million).
HIMS+HERS HERS A DL-0001 Market Cap History: 2020 to 2026
HIMS+HERS HERS A DL-0001's market capitalization history from 2020 to 2026. Data shows growth from $2.70 Billion to $4.88 Billion (17.56% CAGR).
HIMS+HERS HERS A DL-0001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how HIMS+HERS HERS A DL-0001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 82W by Market Capitalization
Companies near HIMS+HERS HERS A DL-0001 in the global market cap rankings as of March 18, 2026.
Key companies related to HIMS+HERS HERS A DL-0001 by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
HIMS+HERS HERS A DL-0001 Historical Marketcap From 2020 to 2026
Between 2020 and today, HIMS+HERS HERS A DL-0001's market cap moved from $2.70 Billion to $ 4.88 Billion, with a yearly change of 17.56%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €4.88 Billion | -25.17% |
| 2025 | €6.53 Billion | +13.73% |
| 2024 | €5.74 Billion | +219.55% |
| 2023 | €1.80 Billion | +35.71% |
| 2022 | €1.32 Billion | +7.30% |
| 2021 | €1.23 Billion | -54.33% |
| 2020 | €2.70 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of HIMS+HERS HERS A DL-0001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.88 Billion USD |
| MoneyControl | $4.88 Billion USD |
| MarketWatch | $4.88 Billion USD |
| marketcap.company | $4.88 Billion USD |
| Reuters | $4.88 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.